How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?

Volume: 18, Issue: 6, Pages: 1291 - 1299
Published: May 1, 2020
Abstract
The implementation of therapeutic drug monitoring (TDM) in the inflammatory bowel disease practice has evolved over the years. In the early days, the focus was merely on measuring and reporting drug concentrations. Later, these concentrations were considered in light of target concentrations that are related to clinical response. This not only allowed passively predicting a patient’s future response, but it also triggered physicians and...
Paper Details
Title
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Published Date
May 1, 2020
Volume
18
Issue
6
Pages
1291 - 1299
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.